#United States #Chicago #Vaccination #American Lung Association #Pneumococcal

Updated CDC Guidelines for Pneumococcal Vaccination

Recent updates from the Centers for Disease Control and Prevention (CDC) focus on improving health safety by expanding pneumococcal vaccination recommendations, primarily targeting adults aged 50 and older, and those younger adults who have underlying health conditions. According to data, about 150,000 people in the United States are hospitalized annually due to pneumococcal pneumonia, which represents the most frequently seen form of bacterial pneumonia.

This push for vaccination awareness is a collaboration between the American Lung Association and Pfizer to ensure the general public is well-informed about the importance and availability of vaccinations that can prevent severe lung diseases. Harold Wimmer, President and CEO of the American Lung Association, emphasized the danger of pneumococcal pneumonia, stating that it can inflict severe health complications that can lead to hospitalization or death.

Who Should Get Vaccinated?

The recommendations extend vaccination eligibility to a broader scope of adults:

• - All adults aged 50 and older
• - Younger adults (aged 19-49) with specific underlying medical conditions. This includes individuals diagnosed with chronic lung diseases, chronic heart diseases, diabetes, or even those who smoke cigarettes.

Importance of Vaccination

Pneumococcal pneumonia occurs regardless of the season and its symptoms can manifest suddenly. Common symptoms encompass fever, chills, cough, difficulty in breathing, and chest pain. Chronic health issues like chronic obstructive pulmonary disease (COPD), asthma, diabetes, and chronic heart disease can significantly heighten the risk of acquiring pneumococcal pneumonia. Adults over 50 are 6.4 times more susceptible to developing the illness compared to younger adults, and for those aged 65 or older, the hospitalization rate spikes to more than tenfold.

Wimmer reminds the public that if they have received vaccinations in the past, it remains critical to consult with healthcare providers about the need for additional vaccinations. He explained that immunity against pneumococcal diseases doesn’t last forever; hence, individuals may still be at risk despite previous vaccinations.

Raising Public Awareness

The combined efforts of the American Lung Association and Pfizer aim to raise significant awareness regarding pneumococcal pneumonia. They are focused on ensuring that at-risk individuals receive pertinent information and have access to vaccination resources. For more information on this initiative and for vaccination inquiries, individuals are encouraged to visit Lung.org/pneumococcal.

About the Organizations

The American Lung Association has been at the forefront of combating lung disease, working diligently to safeguard lung health and enhance educational outreach. They aim to not only defeat lung cancer and advocate for clean air but also improve quality of life for individuals affected by lung diseases and foster a tobacco-free future. With a solid reputation recognized by platforms such as Charity Navigator and GuideStar, they are leading the way in health advocacy.

For questions or to support the American Lung Association's initiatives, outreach can be initiated via their contact number 1-800-LUNGUSA or through visiting their website where you can find local events to get involved with.

By educating the public and expanding vaccination availability, the American Lung Association and CDC are pioneering the fight against pneumococcal pneumonia, ultimately saving lives and improving public health.